The Global Ultomiris Drug Market is experiencing remarkable growth, driven by the increasing prevalence of rare autoimmune and complement-mediated disorders, expanding regulatory approvals, and growing adoption of targeted biologic therapies. Ultomiris has emerged as a breakthrough treatment option, offering long-lasting efficacy and improved patient convenience compared to...